How Thailand is fighting cancer with its first domestically developed drug
Thailand has produced its first-ever locally manufactured cancer treatment drug.
The drug, called Imcranib 100, is a targeted treatment now available at Chulabhorn Hospital.
This marks a major step in Thailand’s efforts to make cancer treatment more affordable and accessible.
The breakthrough comes from the Chulabhorn Royal Academy under the leadership of Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana.
She launched a national effort to improve access to effective cancer treatment by setting up a pharmaceutical factory in 2020 at Phimanmas Residence in Chon Buri.
The facility meets international drug production standards and is the country’s first cancer drug manufacturing site.
Imcranib 100 is part of a new generation of treatments that aim to attack cancer cells more precisely, helping to avoid the harsh side effects of traditional chemotherapy.
Thai scientists have also developed a second major drug called Herdara, a targeted biological medicine for cancer treatment.
It was approved by the country’s Food and Drug Administration in May and is the first of its kind made entirely by Thai researchers without any foreign technology.
This story is written and edited by the Global South World team, you can contact us here.
